Systemic Therapy and Stereotactic Body Radiotherapy in Oligoprogressive Breast Cancer or Lung Cancer
1. Progression-free survival in NSCLC was found to be significant with HR 0.41 compared to breast...
Read More
Oncology
Perioperative pembrolizumab with chemotherapy for gastric and gastroesophageal junction adenocarcinoma improves pathological complete response rate compared with placebo
1. The median overall survival and event-free survival were not statistically different in the...
Read More
#VisualAbstract: Atezolizumab Monotherapy vs Chemotherapy In Advanced Urothelial Carcinoma
1. The median overall survival was similar between both groups, 15.2 months in atezolizumab...
Read More
Testosterone replacement therapy not associated with prostate cancer risk
1. In a population of men with hypogonadism and PSA concentrations less than 3 ng/mL, patients...
Read More
#VisualAbstract: Atezolizumab With Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer
1. Progression-free survival was 4.1 months in the combination arm vs 2.2 months in the...
Read More
Black Men More Likely Than Whites to Have Prostate Cancer
At any given prostate-specific antigen (PSA) level, Black men were more likely than White men to...
Read More
Patients With Cancer May Overly Self-Refer to ED
Adults with cancer may not be using available clinician advice before self-referring to the ED,...
Read More
Guideline-Concordant Care Lower for Black Patients With CRC
Black patients who are newly diagnosed with colorectal cancer (CRC) receive worse and less-timely...
Read More
Smoking Habits of Young Adults Shifted From 2013 to 2021
Over time, young adults are moving away from combustible cigarettes to e-cigarettes, according to...
Read More
#VisualAbstract: Rituximab maintenance therapy following autologous stem cell transplant increased survival in young patients with mantle-cell lymphoma
1. In patients with mantle-cell lymphoma who responded to induction therapy and autologous stem...
Read More
Rate of New Lung Cancer Cases Has Decreased Over Past 5 Years
The rate of new lung cancer cases has decreased, and survival has improved over the past 5 years,...
Read More
Familial Germline EGFR T790M Variant Identified in Lung Cancer
Researchers described a new familial lung cancer caused by an inherited mutation in EGFR in a...
Read More
Risk for Breast Cancer Examined After False-Positive Mammogram
The risk for developing breast cancer after a false-positive mammography result varies with age,...
Read More
Mortality Higher for Black Patients Receiving Neoadjuvant Chemo for Breast Cancer
For patients with early-stage breast cancer treated with neoadjuvant chemotherapy (NACT), Black...
Read More
ASTRO Issues Guidance Related to Partial Breast Irradiation
In a clinical practice guideline published in Practical Radiation Oncology, the American Society...
Read More
Atezolizumab Monotherapy Found Comparable to Chemotherapy in Urothelial Carcinoma
In a study comparing atezolizumab monotherapy with platinum-based chemotherapy in advanced...
Read More
#VisualAbstract: Mirvetuximab soravtansine-gynx compared to chemotherapy in folate receptor alpha-positive platinum resistant ovarian cancer led to improved survival
1. Mirvetuximab soravtansine-gynx (MIRV) significantly improved progression-free survival,...
Read More
Family caregivers of patients with advanced cancer show variations in spiritual coping levels
1. In this cross-sectional study, family caregivers of patients with advanced cancer had moderate...
Read More
Rituximab maintenance therapy following autologous stem cell transplant increased survival in young patients with mantle-cell lymphoma
1. In patients with mantle-cell lymphoma who responded to induction therapy and autologous stem...
Read More
Atezolizumab With Carboplatin in Patients With Metastatic Triple-Negative Breast Cancer
1. Progression-free survival was 4.1 months in the combination arm vs 2.2 months in the...
Read More